ResearcherYonsei UniversityNo recent work listed
Jae Jin Song
Matched on ORCID iD 0000-0001-8183-9550; OpenAlex author ID A5100439345.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 0, last author 1)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 4
2015: 1 paper · 2016: 1 paper
Papers 2
- Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells. Co-author DOI 10.1007/s10495-015-1208-z↗
- Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells. Last author DOI 10.1016/j.cellsig.2015.01.007↗
Closest collaborators
The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Zhezhu Han · 2 shared papers, 2015–2016
- Paper Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-re… DOI 10.1007/s10495-015-1208-z↗
- Paper Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcita… DOI 10.1016/j.cellsig.2015.01.007↗
- Hye Jin Choi · 2 shared papers, 2015–2016
- Paper Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-re… DOI 10.1007/s10495-015-1208-z↗
- Paper Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcita… DOI 10.1016/j.cellsig.2015.01.007↗
- Joo-Hang Kim · 2 shared papers, 2015–2016
- Paper Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-re… DOI 10.1007/s10495-015-1208-z↗
- Paper Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcita… DOI 10.1016/j.cellsig.2015.01.007↗
- Dongxu Kang · 1 shared paper, 2015
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.